Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$0.98 - $1.53 $303,114 - $473,229
-309,300 Closed
0 $0
Q2 2022

Aug 14, 2023

BUY
$5.97 - $9.97 $1.85 Million - $3.08 Million
309,300 New
309,300 $2.59 Million
Q1 2022

May 12, 2023

BUY
$8.44 - $12.49 $6.12 Million - $9.05 Million
724,800 New
724,800 $6.29 Million
Q1 2022

May 09, 2022

SELL
$8.44 - $12.49 $6.12 Million - $9.05 Million
-724,800 Closed
0 $0
Q4 2021

Mar 09, 2022

BUY
$10.12 - $14.07 $7.33 Million - $10.2 Million
724,800 New
724,800 $8.2 Million
Q3 2021

Nov 14, 2022

BUY
$7.25 - $13.23 $5.25 Million - $9.59 Million
724,800 New
724,800 $9.11 Million
Q3 2021

Nov 05, 2021

SELL
$7.25 - $13.23 $5.25 Million - $9.59 Million
-724,800 Closed
0 $0
Q2 2021

Aug 15, 2022

BUY
$8.0 - $9.75 $5.8 Million - $7.07 Million
724,800 New
724,800 $5.89 Million
Q2 2021

Aug 10, 2021

SELL
$8.0 - $9.75 $5.8 Million - $7.07 Million
-724,800 Closed
0 $0
Q1 2021

May 09, 2022

BUY
$8.63 - $10.94 $6.26 Million - $7.93 Million
724,800 New
724,800 $6.7 Million
Q1 2021

May 07, 2021

SELL
$8.63 - $10.94 $7.82 Million - $9.91 Million
-906,000 Closed
0 $0
Q4 2020

Mar 02, 2021

BUY
$8.3 - $13.59 $7.52 Million - $12.3 Million
906,000 New
906,000 $8.76 Million
Q4 2020

Feb 10, 2021

SELL
$8.3 - $13.59 $7.52 Million - $12.3 Million
-906,000 Closed
0 $0
Q3 2020

Nov 12, 2021

BUY
$11.3 - $14.75 $10.2 Million - $13.4 Million
906,000 New
906,000 $11.2 Million
Q3 2020

Nov 10, 2020

SELL
$11.3 - $14.75 $10.2 Million - $13.4 Million
-906,000 Closed
0 $0
Q2 2020

Aug 13, 2021

BUY
$9.52 - $15.98 $8.63 Million - $14.5 Million
906,000 New
906,000 $11.8 Million
Q2 2020

Aug 07, 2020

SELL
$9.52 - $15.98 $4.47 Million - $7.51 Million
-470,000 Closed
0 $0
Q1 2020

May 07, 2021

BUY
$8.0 - $15.48 $3.76 Million - $7.28 Million
470,000 New
470,000 $4.77 Million
Q1 2020

May 08, 2020

SELL
$8.0 - $15.48 $6.35 Million - $12.3 Million
-794,275 Closed
0 $0
Q4 2019

Mar 03, 2020

BUY
$14.82 - $26.79 $11.8 Million - $21.3 Million
794,275 New
794,275 $12.4 Million
Q4 2019

Feb 12, 2020

SELL
$14.82 - $26.79 $11 Million - $19.9 Million
-742,991 Closed
0 $0
Q3 2019

Nov 13, 2020

BUY
$16.02 - $22.47 $11.9 Million - $16.7 Million
742,991 New
742,991 $12.5 Million
Q3 2019

Nov 08, 2019

SELL
$16.02 - $22.47 $10.5 Million - $14.8 Million
-657,081 Closed
0 $0
Q2 2019

Aug 13, 2020

BUY
$16.12 - $22.89 $10.6 Million - $15 Million
657,081 New
657,081 $14.6 Million
Q2 2019

Aug 09, 2019

SELL
$16.12 - $22.89 $7.58 Million - $10.8 Million
-470,000 Closed
0 $0
Q1 2019

May 11, 2020

BUY
$17.58 - $23.97 $8.26 Million - $11.3 Million
470,000 New
470,000 $10.2 Million

Others Institutions Holding GOSS

About Gossamer Bio, Inc.


  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $80.8M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.